SanBio Company Limited announced consolidated earnings results for the six months ended July 31, 2019. The company reported operating revenue of JPY 427 million against JPY 415 million a year ago. Operating loss was JPY 2,385 million against JPY 1,615 million a year ago. Ordinary loss was JPY 2,039 million compared to JPY 1,040 million a year ago. Net loss attributable to owners of parent was JPY 2,048 million against JPY 1,041 million a year ago. Net loss per share was JPY 40.62 against JPY 22.01 a year ago.

For the full year, the company expected operating revenue of JPY 713 million, operating loss of JPY 5,887 million, ordinary loss of JPY 5,390 million and net loss attributable to owners of parent of JPY 5,395 million or JPY 108.48 per share.